Tiziana Life Sciences Ltd
TLSA
$0.81
$0.00991.24%
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.33M | -2.33M | -4.54M | -4.54M | -4.31M |
| Total Depreciation and Amortization | 31.00K | 31.00K | 20.50K | 20.50K | 27.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.65M | 1.65M | 560.50K | 560.50K | 1.18M |
| Change in Net Operating Assets | 842.00K | 842.00K | 1.80M | 1.80M | -2.59M |
| Cash from Operations | 200.00K | 200.00K | -2.15M | -2.15M | -5.70M |
| Capital Expenditure | -7.00K | -7.00K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -500.00K | -500.00K | -- |
| Cash from Investing | -7.00K | -7.00K | -500.00K | -500.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -34.50K | -34.50K | -41.00K | -41.00K | -18.50K |
| Issuance of Common Stock | -- | -- | 12.50K | 12.50K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -127.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 67.50K | 67.50K | -- |
| Cash from Financing | -34.50K | -34.50K | 39.00K | 39.00K | -145.50K |
| Foreign Exchange rate Adjustments | -185.00K | -185.00K | -93.00K | -93.00K | 79.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.50K | -26.50K | -2.71M | -2.71M | -5.76M |